{"version":"1.0","provider_name":"Vistamedica","provider_url":"https:\/\/www.vistamedica.com\/main","author_name":"Diego A. Romero","author_url":"https:\/\/www.vistamedica.com\/main\/author\/daromixnet\/","title":"Identificado un factor desencadenante de leucemia - Vistamedica","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"m7aF1la8Zo\"><a href=\"https:\/\/www.vistamedica.com\/main\/2005\/01\/14\/identificado-un-factor-desencadenante-de-leucemia\/\">Identificado un factor desencadenante de leucemia<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.vistamedica.com\/main\/2005\/01\/14\/identificado-un-factor-desencadenante-de-leucemia\/embed\/#?secret=m7aF1la8Zo\" width=\"600\" height=\"338\" title=\"\u00abIdentificado un factor desencadenante de leucemia\u00bb \u2014 Vistamedica\" data-secret=\"m7aF1la8Zo\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.vistamedica.com\/main\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Madrid, 14 de enero 2005 (E.P)Investigadores de la Escuela de Medicina de la Universidad de Padua (Italia) han descubierto la presencia excesiva de una enzima en las c\u00e9lulas procedentes de pacientes de leucemia linfoc\u00edtica cr\u00f3nica de c\u00e9lulas B (LLC-B), el tipo m\u00e1s com\u00fan de leucemia, lo que podr\u00eda convertir a esta mol\u00e9cula en la base de nuevos tratamientos contra la enfermedad. Los resultados del estudio se publican en la edici\u00f3n digital del 'Journal of Clinical Investigation'."}